Evelo Biosciences, Inc.
EVLO
Revenue
0.00
0.000.00%
-Assets
20.63M
▼-192.00k▼-0.9222%
3 Months ChangeLiabilities
47.33M
▼-19.61M▼-29.29%
3 Months ChangeFree Cash Flow
-20.29M
▲8.80M▲30.25%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-01-26
Form 8-K
ID: 0001193125-24-016885
2023-12-04
Form 8-K
ID: 0001193125-23-287901
2023-11-21
Form 8-K
ID: 0001694665-23-000186
2023-11-09
Form 10-Q
ID: 0001694665-23-000182
2023-10-27
Form 8-K
ID: 0001193125-23-265281
2023-10-17
Form 8-K
ID: 0001694665-23-000163
2023-08-21
Form 8-K
ID: 0001694665-23-000150
2023-08-14
Form 10-Q
ID: 0001694665-23-000146
2023-08-14
Form 8-K
ID: 0001694665-23-000144
2023-07-20
Form 8-K
ID: 0001694665-23-000128